Mayank Mamtani

Mayank Mamtani

#93 out of 1697 analysts
B. Riley Securities
Automatically Tracked
Tracking: 0 Updated: 19 hours ago

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
103.16%
Gain +2.58%
Monthly
-0.32%
Yearly
-3.75%
Drawdown
88.37%
$77,717.07
Equity
Holdings
$77,717.06
Cash
$0.01
Investment
$129,174.01
-$22,283.19
Profit +$1,953.72
Realized
$29,173.76
Unrealized
-$51,456.95
Dividends
$0
$0.01
Cash
Deposits
$100,000.26
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
2.58%
Profit
$1,953.72
Win %
0%
This Week
Compared To Last Week
Gain
-17.21%
Profit
-$16,156.45
Win %
0%
This Month
Compared to last month
Gain
-16.4%
Profit
-$15,244.33
Win %
0%
This Year
Compared to last year
Gain
-18.56%
Profit
-$17,706.91
Win %
58%
Climb Biotherapeutics, Inc. logo
CLYM Climb Biotherapeutics, Inc.
+5.47%
+$2,458.98
Cue Biopharma, Inc. logo
CUE Cue Biopharma, Inc.
-1.64%
-$505.26
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
593
Longs Won
283/585 48%
Profit Factor
0.95
Profitability
Shorts Won
0/8 0%
Standard Deviation
$4,357.79
Average Win
$1,592.71
Best Trade
(Nov 13) $35,957.92
Sharpe Ratio
-88.13
Average Loss
-$1,525.87
Worst Trade
(Jan 24) -$37,211.48
Z-Score
-5.8 (100%)
Commissions
$0
Avg. Trade Length
1m 3w 6d
Expectancy
-$37.58
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss - - - - - - - - - -
Consecutive Losing Trades 51 46 41 36 31 25 20 15 10 5
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
Symbol Quantity Cost Value Comm. Profit ($) Gain (%) Change
Climb Biotherapeutics, Inc. logo
CLYM Climb Biotherapeutics, Inc.
4,368.41 $67,797.79 $47,409.96 - -$20,387.83 -30.07%
+5.47%
Cue Biopharma, Inc. logo
CUE Cue Biopharma, Inc.
1,656.58 $61,376.22 $30,307.1 - -$31,069.12 -50.62%
-1.64%
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV